[Management of wheezing disorders in infants participating in the PARIS birth cohort]

M Herr1, L Nikasinovic, C Foucault

  • 1EA 4064, laboratoire santé publique et environnement, faculté des sciences pharmaceutiques et biologiques, université Paris Descartes, 4, avenue de l'Observatoire, 75006 Paris, France.

Insights

Infant wheezing disorders lead to significant healthcare use, including frequent medical visits and high rates of inhaled anti-asthmatic medication. This highlights the substantial burden of pediatric respiratory conditions.

Area of Science:

  • Pediatric Pulmonology
  • Epidemiology of Respiratory Diseases
  • Public Health

Background:

  • Wheezing disorders are prevalent in young children, yet their management remains unclear.
  • The study investigates healthcare resource utilization for infant wheezing within a birth cohort.

Purpose of the Study:

  • To assess the medical healthcare resource utilization for wheezing disorders in 18-month-old infants.
  • To analyze patterns of medical visits and medication use related to respiratory symptoms.

Main Methods:

  • Utilized data from the Pollution and Asthma Risk: an Infant Study (PARIS) birth cohort.
  • Collected information via a standardized questionnaire administered by a pediatrician during 18-month health checks.
  • Focused on respiratory disorders and related healthcare encounters in the preceding 12 months.

Main Results:

  • Prevalence of wheezing disorders was 28.4% (560/1974) in the past year.
  • Among infants with wheezing, 89.3% sought medical attention for breathing difficulties.
  • High rates of inhaled anti-asthmatic medication (67.2%) and chest physiotherapy (85.1%) were reported.

Conclusions:

  • Infant wheezing disorders are associated with substantial healthcare resource use.
  • France shows a higher utilization of anti-asthmatic medications compared to other European countries for infant wheezing.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation